Market Place
Sourcing Support
Biovica`s Q1 Interim Report: May-July 2025
11 Sep 2025 //
PHARMAWEB
Annual General Meeting Notice for Biovica International AB
22 Aug 2025 //
PHARMAWEB
Biovica Conducts Directed Share Issue Worth MSEK 42.2
13 Aug 2025 //
ACCESSWIRE
Biovica Announces Outcome of Rights Issue
05 Aug 2025 //
ACCESSWIRE
Biovica Launches DiviTum(R) TKa for Use in Early Breast Cancer
25 Jul 2025 //
ACCESSWIRE
Biovica International AB - Annual Report for the Financial Year
27 Jun 2025 //
ACCESSWIRE
Biovica Granted New European Patent
26 Jun 2025 //
ACCESSWIRE
Year-End Report 2024/2025
18 Jun 2025 //
ACCESSWIRE
Biovica resolves SEK 80m rights issue at SEK 0.63/share
11 Jun 2025 //
ACCESSWIRE
Notice of Extra General Meeting in Biovica International AB
11 Jun 2025 //
ACCESSWIRE
Biovica Signs Agreement with Fifth Tier-1 US Biopharma Company
11 Jun 2025 //
ACCESSWIRE
Biovica Secures Three New Work Orders Worth 2.5 MSEK Value
10 Jun 2025 //
ACCESSWIRE
Biovica Sets Financial Targets After Partnerships and Progress
10 Jun 2025 //
ACCESSWIRE
New DiviTum(R) TKa Data Presented at ASCO for Three Cancer Types
23 May 2025 //
ACCESSWIRE
Biovica Signs Major Service Agreement and First 4 MSEK Study
19 May 2025 //
ACCESSWIRE
Biovica partners Tempus to expand DiviTum(R) TKa Reach
13 May 2025 //
ACCESSWIRE
Biovica Q3 Interim report Nov 2024 - Jan 2025
13 Mar 2025 //
ACCESSWIRE
Biovica, Outcomes4Me Partner To Aid Metastatic Breast Cancer Care
12 Mar 2025 //
ACCESSWIRE
Biovica signs new work order with US biotech for TKa testing
10 Mar 2025 //
ACCESSWIRE
Biovica Signs Agreement with American Health Giant
03 Dec 2024 //
ACCESSWIRE
Biovica signs commercial agreement with MediNcrease for DiviTum TKa in US
19 May 2023 //
PHARMABIZ
Announcement from Biovica International AB`s annual general meeting
31 Aug 2022 //
ACCESSWIRE
Biovica Announces Start of TK IMPACT Trial at Washington University of St Louis
24 Nov 2021 //
BIOSPACE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.